Prolia

Short answer: Often no — it’s not automatically “too late” to start hormone therapy in your late 50s, but whether it’s a good idea depends on what symptoms you want treated, how long it’s been since menopause, and your medical history. I have a few quick clarifying questions before more specific guidance: are you asking about menopausal HRT (estrogen ± progestogen) or gender‑affirming HRT? Do you still have a uterus? Any history of breast cancer, blood clots, stroke, liver disease, or uncontrolled high blood pressure? What you should know now (overview) Benefits: Systemic HRT (estrogen ± progestogen) is effective for hot flashes, night sweats, sleep and mood symptoms, and can help prevent bone loss. Local (vaginal) estrogen is very effective for genitourinary symptoms (dryness, painful sex) at low doses with minimal systemic absorption. Timing and risks: Starting systemic HRT within about 10 years of menopause or under about age 60 is generally considered to have a more favorable benefit–risk profile. Starting later (for example well into the 60s) can raise certain risks (blood clots, stroke, and possibly some differences in cardiovascular outcomes), so decisions are more individualized. Contraindications: Active or recent breast or endometrial cancer, active or recent venous thromboembolism (VTE), uncontrolled stroke or heart disease, and unexplained vaginal bleeding are important reasons to avoid or delay systemic HRT. Vaginal estrogen often remains an option even when systemic HRT is contraindicated. Practical options and brand examples Transdermal estradiol (patch): Vivelle‑Dot, Climara, Alora — transdermal patches have a lower risk of blood clots compared with oral estrogen and are a good option for many older people. Oral estradiol: Estrace (micronized estradiol) — effective but oral estrogen has a higher VTE risk than transdermal. Vaginal/local estrogen for GSM (genitourinary syndrome of menopause): Vagifem (vaginal tablet), Estring (vaginal ring), and low‑dose estradiol creams — very useful for vaginal dryness, painful sex, and recurrent urinary symptoms and often safe even if systemic HRT isn’t recommended. Progesterone (if you have a uterus): Prometrium (micronized progesterone) — given with estrogen to protect the lining of the uterus; some clinicians prefer natural micronized progesterone over some synthetic progestins for a possibly better side‑effect profile. Non‑hormonal alternatives for hot flashes: low‑dose SSRI/SNRI (e.g., venlafaxine by prescription), gabapentin; for vaginal dryness, moisturizers and lubricants or ospemifene (Osphena) as a non‑estrogen oral option. Bone protection alternatives: If HRT isn’t suitable for osteoporosis prevention, consider alendronate (Fosamax) or denosumab (Prolia) — discuss with your doctor. Where to get care See your primary care clinician or a gynecologist/menopause clinic for individualized assessment (medical history, risks, baseline mammogram as appropriate, BP, labs). If your question is about gender‑affirming HRT, seek a gender clinic or specialized telehealth service (examples: Fenway Health, Planned Parenthood with trans care, or telehealth providers such as Folx or Plume) for protocols and monitoring. Next steps I recommend Tell me whether this is for menopausal symptoms or gender‑affirming care and a little about your medical history (uterus status, any clot/cancer/heart disease history). I can give more tailored information. Make an appointment with a clinician to review risks and do baseline screening (mammogram if due, BP, review of clot risk). If starting HRT, ask about transdermal estradiol if you have clot risk factors, and about micronized progesterone if you have a uterus. Ask about low‑dose vaginal estrogen if genitourinary symptoms are your main concern. If you want, tell me more about your symptoms and health history and I’ll help you draft questions to bring to your clinician.

Mentioned in position 10 of 14